rosiptor

Aquinox discards lead drug, chops half of its staff in wake of PhIII disaster
Endpoints
Tue, 07/10/18 - 11:44 am
layoffs
Aquinox
rosiptor
clinical trials
Aquinox scraps bladder pain drug after Phase 3 failure
Biopharma Dive
Thu, 06/28/18 - 07:12 pm
Aquinox Pharmaceuticals
rosiptor
clinical trials
Interstitial Cystitis
With the ink on their $25M Astellas deal still drying, Aquinox shares get blasted on PhIII failure
Endpoints
Wed, 06/27/18 - 10:21 am
Aquinox Pharmaceuticals
Astellas
rosiptor
Asia
clinical trials
Interstitial Cystitis
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Thu, 05/10/18 - 09:32 am
Astellas
Aquinox Pharmaceuticals
SHIP1 activator
Japan
Asia
rosiptor